Skip to main content
. 2021 Aug 5;31:e00663. doi: 10.1016/j.btre.2021.e00663

Table 2.

Scientific evidence for the potential application of natural anti-cancerous drugs using nanofibers

Excipient Drug(s) Application Ref.
PA CPT In-vitro and In-vivo on breast cancer cells [34]
PCL CPT In vitro on C2C12 cancer cells [35]
PEG CPT In-vitro and In-vivo on breast and ovarian cancer cells [36]
DNA CPT In-vitro on A549 cancer cells [37]
PLGA CUR In-vitro on carcinoma cancer cells [38]
CS CUR In-vitro on MCF-7, HEP G2 and L929 cancer cells [39]
CS CUR In-vitro on breast cancer cells [40]
PLGA-PEG CUR/CH In-vitro and In-vivo on breast cancer cells [17]
PLGA-PCL QUE In-vitro on Hepatocellular carcinoma (HepG2) cancer cells [41]
PCL/PEO/PLA/PLGA QUE In-vitro on breast cancer cells [42]
SoA/CS QUE In-vitro on colon cancer cells [43]
CA/PEG QUE In-vtiro on HeLa tumor and SH-4 skin cancer cells (melanoma) [44]
PCL EO In-vitro on MCF-7 cancer cells [45]